JP2024527934A5 - - Google Patents

Info

Publication number
JP2024527934A5
JP2024527934A5 JP2024504809A JP2024504809A JP2024527934A5 JP 2024527934 A5 JP2024527934 A5 JP 2024527934A5 JP 2024504809 A JP2024504809 A JP 2024504809A JP 2024504809 A JP2024504809 A JP 2024504809A JP 2024527934 A5 JP2024527934 A5 JP 2024527934A5
Authority
JP
Japan
Prior art keywords
approximately
solvent
compound
solution
reducing agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024504809A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527934A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/038343 external-priority patent/WO2023009521A1/en
Publication of JP2024527934A publication Critical patent/JP2024527934A/ja
Publication of JP2024527934A5 publication Critical patent/JP2024527934A5/ja
Pending legal-status Critical Current

Links

JP2024504809A 2021-07-26 2022-07-26 二官能性化合物を製造する方法 Pending JP2024527934A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163225858P 2021-07-26 2021-07-26
US63/225,858 2021-07-26
PCT/US2022/038343 WO2023009521A1 (en) 2021-07-26 2022-07-26 Methods of manufacturing a bifunctional compound

Publications (2)

Publication Number Publication Date
JP2024527934A JP2024527934A (ja) 2024-07-26
JP2024527934A5 true JP2024527934A5 (https=) 2025-08-04

Family

ID=83508570

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024504809A Pending JP2024527934A (ja) 2021-07-26 2022-07-26 二官能性化合物を製造する方法

Country Status (10)

Country Link
US (2) US12286419B2 (https=)
EP (1) EP4377296A1 (https=)
JP (1) JP2024527934A (https=)
KR (1) KR20240040769A (https=)
CN (1) CN117715889A (https=)
AU (1) AU2022319702A1 (https=)
CA (1) CA3227425A1 (https=)
IL (1) IL309839A (https=)
MX (1) MX2024001118A (https=)
WO (1) WO2023009521A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019011200B1 (pt) 2016-12-01 2021-12-28 Arvinas Operations, Inc Derivados de tetrahidronaftaleno e tetrahidroisoquinolina como degradadores do receptor de estrogênio
KR20220054347A (ko) 2019-08-26 2022-05-02 아비나스 오퍼레이션스, 인코포레이티드 에스트로겐 수용체 분해제로서의 테트라히드로나프탈렌 유도체로 유방암을 치료하는 방법
CA3227425A1 (en) 2021-07-26 2023-02-02 Arvinas Operations, Inc. Methods of manufacturing a bifunctional compound
WO2025245032A1 (en) 2024-05-20 2025-11-27 Arvinas Operations, Inc. Methods of manufacturing a bifunctional compound
WO2026018182A1 (en) 2024-07-19 2026-01-22 Pfizer Inc. Process for preparing a cis-1,2-diaryltetralin derivative

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885363A (en) 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
MX174467B (es) 1986-01-23 1994-05-17 Squibb & Sons Inc 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
US5965107A (en) 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5808091A (en) 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
US5608110A (en) 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
ES2114209T3 (es) 1993-07-19 1998-05-16 Resolution Pharm Inc Queladores de radionuclidos de tipo hidrazino que tienen una configuracion n3s.
US5574140A (en) 1993-09-03 1996-11-12 Resolution Pharmaceutical Inc. Hydrazino-type N2 S2 chelators
US5662885A (en) 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
US6093382A (en) 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
ES2885769T3 (es) * 2012-08-09 2021-12-15 Celgene Corp Una forma sólida de clorhidrato de (s)-3-(4-((4-morpholinometil)bencil)oxi)-1-oxoisoindolin-2-il)piperidina-2,6-diona
BR112019011200B1 (pt) 2016-12-01 2021-12-28 Arvinas Operations, Inc Derivados de tetrahidronaftaleno e tetrahidroisoquinolina como degradadores do receptor de estrogênio
EP4406609A3 (en) 2017-05-30 2024-10-02 Day One Biopharmaceuticals, Inc. Method for producing optically active compound
EP3412666A1 (en) * 2017-06-07 2018-12-12 Albany Molecular Research, Inc. Process and intermediates for the preparation of bcl-2 inhibitors including venetoclax through reductive amination
US10717703B2 (en) * 2017-08-21 2020-07-21 Celgene Corporation Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate
IL302595A (en) * 2018-04-13 2023-07-01 Arvinas Operations Inc Servalon ligands and bifunctional compounds containing them
JP7307796B2 (ja) 2019-09-23 2023-07-12 アキュター バイオテクノロジー インコーポレイテッド アンドロゲン受容体分解活性を有する新規の置換キノリン-8-カルボニトリル誘導体およびその使用
EP3835298B1 (en) 2019-12-12 2024-06-26 Accutar Biotechnology Inc. Novel chroman derivatives having estrogen receptor degradation activity and uses thereof
CA3227425A1 (en) 2021-07-26 2023-02-02 Arvinas Operations, Inc. Methods of manufacturing a bifunctional compound
CN113816927B (zh) 2021-11-23 2022-02-25 苏州国匡医药科技有限公司 一种arv-471中间体的制备方法
CN117126133A (zh) 2023-08-14 2023-11-28 中国海洋大学 一种化合物及其用途

Similar Documents

Publication Publication Date Title
JP2024527934A5 (https=)
IL309839A (en) Methods for producing a bifunctional compound
JP4199310B2 (ja) トルテロジンの製法
JPH09504024A (ja) 置換2,5−ジアミノ−3−ヒドロキシヘキサンの製造方法
JP6231010B2 (ja) アクリルアミド−2−メチルプロパンスルホン酸(a)の塩を生成する方法、アクリルアミド−2−メチルプロパンスルホン酸(a)又はその塩、及びそれを用いた共重合体の製造方法
JP2011524402A (ja) ダビガトランの合成の中間体の製造方法
CN106632267B (zh) 一种伏立康唑的合成方法
EP2305638B1 (en) Asymmetric azine compound and method for producing the same
CA2975072A1 (en) Method for producing pyrazinecarboxamide compound and synthetic intermediate thereof
CN102712593B (zh) 2-氨基-4-三氟甲基吡啶的生产方法
CA3229553A1 (en) A process for making osimertinib
JPWO2011001976A1 (ja) スレオ−3−(3,4−ジヒドロキシフェニル)−l−セリンの製造法
EP1907396B1 (fr) Procede de preparation de la 4 -amino-4'-demethyl-4-desoxypodophyllotoxine
CN117466867B (zh) 一种合成沃诺拉赞的新工艺及其应用
JP2025523682A (ja) 複素環式化合物の調製方法
JP5166747B2 (ja) アルキルアミノピリジン類の精製方法
RU2409554C1 (ru) Способ получения 4-(3,4-диаминофенокси)бензойной кислоты
CN104870436B (zh) 用于制备(2‑甲基‑1‑(3‑甲基苄基)‑1H‑苯并[d]咪唑‑5‑基)(哌啶‑5‑基)甲酮的方法
CA2647586A1 (en) Process for producing 3-[4-(1,1-dimethyl-propyl)-phenyl]-2-methyl-propionaldehyde and cis-4-{3-[4-(1,1-dimethyl-propyl)-phenyl]-2-methyl-propyl}-2,6-dimethyl-morpholine (amorolfine)
CN115677654B (zh) 一种盐酸阿替卡因的制备方法
JP2016511761A (ja) 4−ピペリジン−4−イル−ベンゼン−1,3−ジオール及びその塩の合成方法、並びに新規化合物tert−ブチル4−(2,4−ジヒドロキシ−フェニル)−4−ヒドロキシ−ピペリジン−1−カルボキシレート
CN117229164B (zh) 一种2-氨基丁酰胺的合成方法
RU2741389C1 (ru) Способ получения промежуточного соединения для синтеза лекарственного средства
CN119698404A (zh) 用于制备和分离某些介离子类杀有害生物剂的中间体的方法
JP5082340B2 (ja) 3−アミノ−6−クロロピリダジンの製造方法